Exclusive

Publication

Byline

Location

HEG Advanced Materials rises after subsidiary inks MoU with Indus Towers for energy storage solutions

Mumbai, Sept. 30 -- Under the MoU, Replus intends to make available dedicated Battery Energy Storage System (BESS) production capacity of 1.5 GWh over a two-year period to support the evolving energy ... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamide Compared with ARPI or Docetaxel in Patients with Metastatic Castration Resistant Prostate Cancer Previously Treated with Abiraterone Acetate (Himalayas-1)

Singapore, Sept. 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutam... Read More


Singapore Clinical Trial: An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-08634404 in Combination With Chemotherapy Versus Pembrolizumab in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent Mismatch Repair (MMR) Proficient Endometrial Cancer

Singapore, Sept. 30 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-086... Read More


Singapore Clinical Trial: A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib (RMC-9805) as First Line Treatment in Patients With Metastatic Non-squamous RAS G12D-Mutated Non-small Cell Lung Cancer (RASolve 308)

Singapore, Sept. 30 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy W... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Patients With Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma (RASolute 309)

Singapore, Sept. 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Ve... Read More


OpenAI Dots vs Meta Muse: How AI agents differ in features, use cases

New Delhi, Sept. 30 -- The AI race is moving beyond chatbots, as OpenAI and Meta build agents that can perform tasks rather than simply answer questions. While OpenAI's Dots was announced during DevDa... Read More


Three militants killed in Mir Ali security operationPublished on: September 30, 2026 10:02 AM

Pakistan, Sept. 30 -- Security forces killed three militants during an intelligence-based operation in Mir Ali, North Waziristan, according to security sources. The operation targeted suspected hideou... Read More


ArMee Infotech slides on debut

Mumbai, Sept. 30 -- The stock debuted at Rs 368.85 on the BSE, a premium of 1.64% over its issue price. So far, the stock has hit a high of Rs 372 and a low of Rs 320. On the BSE, over 5.77 lakh shar... Read More


Nifty trades above 22,750 mark; media shares jump

Mumbai, Sept. 30 -- The key equity benchmarks traded with moderate gains in morning trade, supported by eased crude oil prices from elevated levels and a moderation in US Treasury bond yields. The Nif... Read More


Clinical Trial: Hypofractionated Radiotherapy in Older Adults With Head and Neck Squamous Cell Carcinoma

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07847060) titled 'Hypofractionated Radiotherapy in Older Adults With Head and Neck Squamous Cell Carcinoma' ... Read More